These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20064872)

  • 1. Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study.
    Mackie SL; Hensor EM; Haugeberg G; Bhakta B; Pease CT
    Rheumatology (Oxford); 2010 Apr; 49(4):716-22. PubMed ID: 20064872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
    González-Gay MA; García-Porrúa C; Vázquez-Caruncho M; Dababneh A; Hajeer A; Ollier WE
    J Rheumatol; 1999 Jun; 26(6):1326-32. PubMed ID: 10381051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
    Durkin SR; Athanasiov PA; Crompton JL
    Aust Fam Physician; 2006 Nov; 35(11):889-91. PubMed ID: 17099810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PMR and GCA: steroids or bust.
    Adizie T; Dasgupta B
    Int J Clin Pract; 2012 Jun; 66(6):524-7. PubMed ID: 22607502
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
    Bahlas S; Ramos-Remus C; Davis P
    J Rheumatol; 1998 Jan; 25(1):99-104. PubMed ID: 9458211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.
    Salvarani C; Boiardi L; Macchioni P; Rossi F; Tartoni P; Casadei Maldini M; Mancini R; Beltrandi E; Portioli I
    Ann Rheum Dis; 1995 Aug; 54(8):640-4. PubMed ID: 7677440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polymyalgia rheumatica and giant cell arteritis--first results of a year-long study].
    Rovenský J; Tuchynová A; Poprac P; Blazíková S; Bosák V; Stvrtinová V
    Vnitr Lek; 2006; 52(7-8):691-6. PubMed ID: 16967610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
    Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
    Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigens in patients with giant cell arteritis and polymyalgia rheumatica.
    Hunder GG; Taswell HF; Pineda AA; Elveback LR
    J Rheumatol; 1977; 4(3):321-3. PubMed ID: 926109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymyalgia rheumatica and giant-cell temporal arteritis].
    Tereshchenko IV
    Klin Med (Mosk); 2006; 84(8):25-30. PubMed ID: 17087187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial giant cell arteritis and polymyalgia rheumatica: aggregation in 2 families.
    Fietta P; Manganelli P; Zanetti A; Neri TM
    J Rheumatol; 2002 Jul; 29(7):1551-5. PubMed ID: 12136919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longterm therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis.
    Narváez J; Nolla-Solé JM; Clavaguera MT; Valverde-García J; Roig-Escofet D
    J Rheumatol; 1999 Sep; 26(9):1945-52. PubMed ID: 10493675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyalgia rheumatica and giant cell arteritis. Avoiding management traps.
    de Jager JP
    Aust Fam Physician; 2001 Jul; 30(7):643-7. PubMed ID: 11558196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
    Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
    Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
    J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Follow-up studies in polymyalgia rheumatica and temporal arteritis].
    Li J; Tang FL; Wang XD; Yu JH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):643-5. PubMed ID: 12905697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.
    Borresen SW; Thorgrimsen TB; Jensen B; Hilsted L; Bartels EM; Feldt-Rasmussen U; Locht H
    Rheumatology (Oxford); 2020 Oct; 59(10):2764-2773. PubMed ID: 32031663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymyalgia rheumatica and giant-cell arteritis].
    Glazunov AV; Zhiliaev EV; Toldieva FA; Dzhanashiia PKh
    Klin Med (Mosk); 2005; 83(11):39-45. PubMed ID: 16404938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment and diagnosis of polymyalgia rheumatica and temporal arteritis].
    Gran JT
    Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3387. PubMed ID: 14713975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation.
    Pease CT; Haugeberg G; Morgan AW; Montague B; Hensor EM; Bhakta BB
    J Rheumatol; 2005 Jun; 32(6):1043-6. PubMed ID: 15940765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.